Security Snapshot

Renalytix plc - Ordinary shares, nominal value 0.0025 per share Institutional Ownership

CUSIP: G7489R108

13F Institutional Holders and Ownership History from Q1 2019 to Q2 2022

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Security identity 1 fact
Issuer context 1 fact
Shares outstanding
328,915,843
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share is tracked under CUSIP G7489R108.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 2 to 0 between Q1 2022 and Q2 2022.
  • Reported value moved from $622,000 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

G7489R108

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
14
Latest
n/a
Rows shown
1-14 of 14
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q2 0 $0 -$622,000 0
2022 Q1 175,206 $622,000 -$401,000 $3.54 2
2021 Q4 222,931 $1,872,000 -$3,386 $8.40 3
2021 Q3 223,334 $2,183,000 -$188,252 $9.78 3
2021 Q2 242,611 $3,620,000 -$1,478,238 $14.92 3
2021 Q1 341,675 $4,431,000 -$308,296 $12.97 2
2020 Q4 365,446 $2,435,000 -$266,332 $6.66 2
2020 Q3 409,311 $2,246,000 -$1,181,473 $5.49 3
2020 Q2 630,301 $4,172,000 +$689,922 $6.55 3
2020 Q1 526,573 $1,482,000 +$167,772 $2.73 3
2019 Q4 463,756 $2,148,000 +$712,033 $4.82 3
2019 Q3 313,019 $943,000 +$101,003 $3.01 2
2019 Q2 278,519 $984,000 +$789,294 $3.48 2
2019 Q1 62,000 $88,000 +$88,000 $1.42 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .